New breast cancer drug study challenges tamoxifen lead
Final results from a large NCI funded study in nearly 20,000 high risk postmenopausal women show raloxifene and tamoxifen equally reduce serious breast cancers. Raloxifene lowers uterine cancer and blood clot risks but statistical significance is unclear and long term benefit remains uncertain.
MENTIONED IN THIS ARTICLE
Atlanta
National Cancer Institute
Len Lichtenfeld
The
American Cancer Society
Ford
Eli Lilly & Co
Journal of the American Medical Association
Joseph Costantino
University of Pittsburgh
FDA eyed test to time induced labor in pregnancy
A clear vaginal fibronectin test could guide when to induce labor if FDA approves. Doctors weigh benefits against risks amid rising inductions since 1989, with positive results hinting at quicker vaginal births and negative results linked to more C-sections. critics caution against overuse and changing obstetric practice.
MENTIONED IN THIS ARTICLE
Washington
Food and Drug Administration
Michael Randell
Atlanta
Randell
FDA
Adeza Biomedical
Peter Bernstein
New York
Montefiore Medical Center
Mayo Clinic bids farewell to conjoined twins Abbigail Isabelle Carlsen
Mayo Clinic in Rochester says goodbye to Abbigail and Isabelle Carlsen after successful separation. Born November 29 they were joined at the diaphragm pancreas and liver sharing a bile duct and intestine. They were separated May 12 and depart as healthy six month olds. Parents Amy and Jesse Carlsen of Fargo ND attended the send off at St Marys Hospital with a celebratory cake and photographers. Dr Christopher Moir led the surgical team and noted the transition from a bright operating room to the world outside.
MENTIONED IN THIS ARTICLE
Abbigail Carlsen
Jesse
Isabelle
Amy
Mayo Clinic
Fargo, N.D
Rochester
Minn
Abbigail
Isabelle Carlsen
Jesse Carlsen
Fargo
N.D
St. Marys Hospital
Mayo
Christopher Moir
Moir
Child safety seats beat seat belts in child crash deaths
A study by The Children's Hospital of Philadelphia finds children ages 2 to 6 in rear seat seats risk 28 percent lower death odds with child safety or booster seats than with belts. Even with gross misuse, death risk drops 21 percent. Dr. Dennis Durbin notes age appropriate rear restraints maximize safety. The Archives of Pediatric and Adolescent Medicine covers the findings, following Freakonomics authors Levitt and Dubner.
MENTIONED IN THIS ARTICLE
Washington
Children’s Hospital of
Philadelphia
Dennis Durbin
Philadelphia Hospital
Steven D. Levitt
Stephen J. Dubner
Also Mentioned on This Page
American Society of Clinical Oncology
Cancer Institute
Roy Herbst
University of Texas M.D. Anderson Cancer Center
Leslie Ford
SIUC
Children of Siuc
S.A.Q
Siu.edu
Tss
Thern ™ University
Dale
Procter & Gamble
J. Bradley Wilmoth Law Offices
Schlichter Bogard & Denton
Schlicter Bogard & Denton
North Illinois
Suite
Swansea
This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!